Skip to main content

Pelvic Floor Disorders

0
Pipeline Programs
5
Companies
4
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
Pelvic floor muscle trainingN/A1 trial
Active Trials
NCT06461234Recruiting1,360Est. Nov 2026
Elidah
ElidahCT - Newtown
1 program
Surface electrical stimulationN/A1 trial
Active Trials
NCT03528928Completed8Est. Jan 2019
Pfizer
PfizerNEW YORK, NY
1 program
WorkshopN/A1 trial
Active Trials
NCT02758561Completed80Est. Nov 2017
Joylux
JoyluxWA - Seattle
1 program
vSculptN/A1 trial
Active Trials
NCT03073824Completed65Est. Nov 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
UNION therapeuticsPelvic floor muscle training
ElidahSurface electrical stimulation
JoyluxvSculpt
PfizerWorkshop

Clinical Trials (4)

Total enrollment: 1,513 patients across 4 trials

NCT06461234UNION therapeuticsPelvic floor muscle training

Pelvic Floor Rehabilitation of Female Pelvic Floor Dysfunction

Start: May 2024Est. completion: Nov 20261,360 patients
N/ARecruiting
NCT03528928ElidahSurface electrical stimulation

Viewing Surface Electrical Stimulation on Pelvic Floor With Ultrasound

Start: Apr 2018Est. completion: Jan 20198 patients
N/ACompleted

A Long-term Evaluation of a Novel Intravaginal Device

Start: Mar 2017Est. completion: Nov 201865 patients
N/ACompleted

Motivational Interviewing in Women's Pelvic Wellness Education

Start: May 2016Est. completion: Nov 201780 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 1,513 patients
5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.